We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCirata Regulatory News (CRTA)

Share Price Information for Cirata (CRTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.00
Bid: 44.50
Ask: 45.95
Change: 0.00 (0.00%)
Spread: 1.45 (3.258%)
Open: 44.50
High: 44.50
Low: 44.00
Prev. Close: 44.00
CRTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

9 Jan 2024 07:00

RNS Number : 0121Z
Cirata PLC
09 January 2024
 

9 January 2024

Cirata plc

("Cirata" or the "Company")

Trading Update

 

Trading in line with management expectations

YE Cash balance exceeds expectations.

 

 

Cirata plc (LSE: CRTA), announces a trading update for the quarter period ended 31 December 2023 ahead of reporting its preliminary results.

 

 

Trading update

 

Cirata's closing cash balance at 31 December 2023 is $18.2m compared to a guidance of $16.0m - $16.5m. This is due to good cash collections and strong cost management during the period. Cirata is targeting cash flow breakeven as we exit FY 2024.

 

The Company expects to announce that bookings[1] in Q4 2023 were $2.7m (Q4 2022: $2.2m), representing c.23% growth year-on-year. Management has highlighted previously some slippage in Q2 and Q3; Q4 was no exception with transactions moving out of Q4 into 2024.

 

Cirata expects FY23 H2 bookings to be $4.4m (FY 22 H2, $4.1m) representing c.7% year-on-year growth and within our previously stated guidance of $4.3m - $6.0m.

 

The Company has seen sequential growth in FY23 in bookings, from Q2, Q3 through to Q4, in both Data Integration (DI) and Application Lifecycle Management (ALM). The approximate mix of DI to ALM bookings in Q4 was 57% to 43%, respectively.

 

During FY23 H2, 8 (DI)[2] contracts were closed, including 5 new contracts and 3 renewals. Of note are the previously announced contracts within the Automotive sector including General Motors, and validation of the 'land and expand' strategy with a marquee financial services company, NatWest and the landing of a new logo, Experian. 

 

The pipeline build is progressing in line with Management expectations. The focus as we exit FY2023 is to leverage the completed workstreams from the Turnaround plan into significantly improved pipeline conversion and greater levels of visibility for the business. 

 

 

New sales organization

 

Historically inadequate focus on sales pipeline management has resulted in some slippage of the closure of contracts. As we have referenced in the Turnaround Plan, which sets the stage for growth in FY24, we have addressed many of the predictability weaknesses in the sales & marketing process.

 

Today, we announce the final step of the Turnaround plan, realigning the Go-to-Market resources to better focus our team on the opportunities ahead and to drive world-class selling disciplines of enterprise software. With this realignment Rich Baker has been appointed as Chief Revenue Officer (CRO) for International, Chris Cochran has joined the leadership team as CRO for North America and Justin Holtzinger has begun the work to revitalize our ALM opportunity as CRO ALM. All three business heads report directly to Stephen Kelly, CEO. With these changes, a management layer has been removed. This flattened, more focused structure will improve visibility around pipeline build, predictability, and closure rates.

 

 

Stephen Kelly, Chief Executive Officer, commented:

 

"FY2023 has been an eventful year for all Cirata stakeholders, a near collapse of the business followed by a herculean effort to rebuild from the ground up. The March 9 announcement represented an existential crisis. Against all odds, the turnaround is well underway. Our Q3 and our Q4 reflect the first steps of a company coming back 'off the canvas'. Sequential growth in bookings through Q2, Q3, Q4 and transacting with companies such as GM, NatWest and Experian amplify the progress this company has made since the dark days after March 9. We completed the FY23 Turnaround Plan and now shift gears into the FY24 Growth Plan. We are getting into our stride, but this is minimum table stakes - we need to drive a much higher quality execution in our Go-to-Market model. The new structure of our sales organization with the leadership of Rich, Chris and Justin reflects a flatter, sharper, more customer focused Cirata. My personal thanks go to my colleagues and shareholders for their trust, diligence, and patience as we set the stage for growth in FY24. I am excited for the year that lies ahead."

 

 

Investor disclosures

 

An accompanying video presentation of the FY23 Q4 trading update will be available on the Company's website shortly after the release of this RNS.

 

Investors should expect the preliminary full year FY2023 results update between mid-March and mid-April 2024. Cirata will provide full year 2024 guidance for both bookings and December 31, 2024 year-end cash balance in the earlier of the Q1 Trading Update or the FY23 preliminary results. An in-depth review and commentary of the Turnaround Plan will be provided in the FY23 results.

 

An unaudited version of the "KPI tracker" will in future be posted on the Company's website as soon as practically possible after the closure of the quarter. We will continue to provide quarterly trading updates throughout the year as soon as possible after the quarter close.

 

This announcement contains information that qualifies or may qualify as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Larry Webster, Company Secretary. 

 

 

For further information, please contact: 

 

Cirata plc

Via FTI Consulting

Stephen Kelly, Chief Executive Officer

Ijoma Maluza, Chief Financial Officer

Daniel Hayes, Investor Relations

FTI Consulting

+44 (0)20 3727 1137

Matt Dixon / Kwaku Aning / Usama Ali

 

Stifel (Nomad and Joint Broker)

+44 (0)20 7710 7600

Fred Walsh / Richard Short / Tom Marsh

 

Liberum (Joint Broker)

 

+44 (0)20 3100 2000

Max Jones / Ben Cryer / Miquela Bezuidenhoudt

 

About Cirata

 

Cirata accelerates data-driven revenue growth by automating data transfer and integration to modern cloud analytics and AI platforms without downtime or disruption. With Cirata, data leaders can leverage the power of AI and analytics across their entire enterprise data estate to freely choose analytics technologies, avoid vendor, platform, or cloud lock-in while making AI and analytics faster, cheaper, and more flexible. Cirata's portfolio of products and technology solutions make strategic adoption of modern data analytics efficient and automated. For more information about Cirata, visit www.cirata.com

 

 


[1] All reported data relating to the Q4 and FY23 H2 trading update are unaudited.

[2] Data Integration solutions (DI) includes Live Data Migrator (LDM) and Live Data Plane (LDP).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLTLEITIIS
Date   Source Headline
24th Apr 20247:00 amRNSDirectorate Change
17th Apr 20243:05 pmRNSAnnual Report & Notice of AGM
9th Apr 20247:00 amRNSQ1 FY24 Trading Update
4th Apr 20247:00 amRNSFinal Results
6th Mar 20245:19 pmRNSHolding(s) in Company
4th Mar 20242:53 pmRNSHolding(s) in Company
21st Feb 20241:27 pmRNSHolding(s) in Company
15th Feb 20244:27 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSChair appointment
9th Jan 20247:00 amRNSTrading Update
4th Jan 20243:10 pmRNSTotal Voting Rights
4th Jan 20242:41 pmRNSHolding(s) in Company
3rd Jan 20245:40 pmRNSHolding(s) in Company
2nd Jan 20249:32 amRNSNotice of Q4 FY23 Trading Update
14th Dec 20236:12 pmRNSBlock Listing Application
12th Dec 20235:32 pmRNSGrant of Share Options to PDMRs
12th Dec 20238:29 amRNSHolding(s) in Company
7th Dec 20237:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSTotal Voting Rights
5th Dec 202310:25 amRNSHolding(s) in Company
24th Nov 20235:40 pmRNSDirector/PDMR Shareholding
23rd Nov 202310:08 amRNSHolding(s) in Company
21st Nov 20235:41 pmRNSHolding(s) in Company
21st Nov 20231:28 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSDirector/PDMR Shareholding
17th Nov 20235:54 pmRNSDirector/PDMR Shareholding
8th Nov 20231:18 pmRNSHolding(s) in Company
7th Nov 20232:39 pmRNSTotal Voting Rights
2nd Nov 20237:00 amRNSChange of Auditor
27th Oct 20235:12 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSTrading Update and Outlook
6th Oct 202312:12 pmRNSHCSC renews contract
6th Oct 202311:24 amRNSHolding(s) in Company
5th Oct 202310:39 amRNSNotice of Q3 FY23 Trading Update
5th Oct 20239:00 amRNSNatWest expands contract
5th Oct 20237:00 amRNSConfirmation of Ticker Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.